CU23480B7 - METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM - Google Patents
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUMInfo
- Publication number
- CU23480B7 CU23480B7 CU20050166A CU20050166A CU23480B7 CU 23480 B7 CU23480 B7 CU 23480B7 CU 20050166 A CU20050166 A CU 20050166A CU 20050166 A CU20050166 A CU 20050166A CU 23480 B7 CU23480 B7 CU 23480B7
- Authority
- CU
- Cuba
- Prior art keywords
- testosterone
- serum
- pharmaceutical compositions
- acceptable levels
- methods
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title abstract 5
- 210000002966 serum Anatomy 0.000 title abstract 3
- 229960003604 testosterone Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- -1 testosterone ester Chemical class 0.000 abstract 1
- 229960000746 testosterone undecanoate Drugs 0.000 abstract 1
- UDSFVOAUHKGBEK-CNQKSJKFSA-N testosterone undecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 UDSFVOAUHKGBEK-CNQKSJKFSA-N 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con composiciones farmacéuticas, formuladas para administración inyectable, la cual comprende un éster de testosterona, en particular undecanoato de testosterona, en un vehículo que comprende aceite de castor y un co-solvente. Posterior a inyectar la composición de acuerdo a un esquema de administración particular, niveles aceptables de testosaterona en suero en un rango fisiológicamente normal es logrado por un largo período. Esto permite el uso de las composiciones en terapia de reemplazo hormonal y anticoncepción masculina sin monitoreo concominante de los niveles de testosterona en suero de un individuoThe present invention relates to pharmaceutical compositions, formulated for injectable administration, which comprises a testosterone ester, in particular testosterone undecanoate, in a vehicle comprising castor oil and a co-solvent. After injecting the composition according to a particular administration schedule, acceptable levels of serum testosaterone in a physiologically normal range is achieved for a long period. This allows the use of the compositions in hormone replacement therapy and male contraception without concomitant monitoring of the serum testosterone levels of an individual
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23480B7 true CU23480B7 (en) | 2010-01-22 |
Family
ID=41694890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23480B7 (en) |
-
2005
- 2005-09-12 CU CU20050166A patent/CU23480B7/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056095A (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM | |
| NI201000193A (en) | ORAL FORMULATIONS OF CITIDINE ANALOGUES AND METHODS OF USE OF THE SAME. | |
| ECSP034654A (en) | STEROID HORMONE PRODUCTS AND METHODS TO PREPARE THE SAME | |
| ES2524320T3 (en) | Composition for the prevention or treatment of disease associated with thrombus or embolus | |
| AR048705A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | |
| AR107285A2 (en) | VACCINE | |
| CL2008002720A1 (en) | Transdermic pharmaceutical composition for nebulizing, without alcohol, comprising one or more drugs, the enhancers of transdermal penetration diethylene glycol ethers or ester sunscreens, and non-volatile liquids; measured nebulization dosing device comprising it; manufacturing method; And its use. | |
| HN2008000621A (en) | METHOD FOR PREVENTIVE HORMONAL ANTICOPCEPTION UNDER DEMAND | |
| CR10489A (en) | PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS | |
| UY30462A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID. | |
| PE20091949A1 (en) | SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE | |
| CR20170130A (en) | FORMULATIONS OF LIOFILIZED THERAPEUTIC PEPTIBODIES | |
| ECSP066715A (en) | ||
| PE20211588A1 (en) | COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE | |
| CL2008000876A1 (en) | PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE THAT INCLUDES A PHOSPHOLIPID COMPONENT COMPOSED BY BIPOLAR PHOSPHOLIPIDS OF NATURAL ORIGIN AND AN OLEOUS COMPONENT COMPOSED BY NATURAL OIL ORIGINS EMULSIONED IN WATER; PREPARATION PROCEDURE | |
| MX2012003519A (en) | Formulations comprising triptan compounds. | |
| AR057060A1 (en) | TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL | |
| ECSP034624A (en) | COMBINATION OF GAVA AGONIST AND INHIBITORS OF SORBITOL-DESHIDROGENASA | |
| PE20070329A1 (en) | COMPOSITIONS WITH ESTROGENS AND THERAPEUTIC METHODS FOR THEIR USE | |
| HRP20160108T1 (en) | Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction | |
| MX2012002830A (en) | Stable hyaluronan/steroid formulation. | |
| AR057946A1 (en) | FORMULATION OF SUSTAINED RELEASE ZONISAMIDE | |
| CO6280503A2 (en) | NEURTURINE CONJUGATES NEW FOR PHARMACEUTICAL USE | |
| BRPI0519070A2 (en) | lyophilized keratinocyte growth factor composition, methods for preparing a lyophilized keratinocyte growth factor, and for treating a disease, and kit for preparing an aqueous pharmaceutical composition | |
| AR059743A1 (en) | PHARMACEUTICAL FORMULATIONS OF A CRYSTALLINE FORM OF MONOHIDRATE OF 2- (3- FLUOR-4- HYDROXYPHENYL) -7- VINIL-1,3- BENZOAXOL-5-OL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |